Endonovo Therapeutics Inc (ENDV)

[Schuulaces]

Endonovo Therapeutics, Inc. DD Packet

$ENDV has the only FDA Approved product that is cleared to reduce pain and edema post-operatively.

Pair that with the Acquisition of Western Star Concrete, which is scheduled to close this month, and the significant potential for synergies under normal operating conditions estimate the generation of revenues between $30 - $60M per year.

$ENDV has LOI’s for two additional companies.
- Marine Pylon Footing company located in the Northeastern U.S.
- Roofing Company with a National Footprint.

Based on 12-month trailing unaudited financials, all three acquisitions are indicating roughly $50 Million in revenues, each. Also, each company is estimating roughly $5 to $6.3 Million in EBITDA each.